What We're Reading: Page 343
Industry reads hand-picked by our editors
Apr 15, 2016
-
Reuters
WHO group backs Sanofi's vaccine in areas with high dengue rates
-
Bloomberg
Bill Miller Buys Valeant Stock on Bet It Could Double
-
FierceBiotech
Bristol-Myers expands I/O hub, may hire up to 150 more for discovery team
-
Renaissance Capital
No IPO in sight: GenSight Biologics withdraws $65 million IPO
Apr 14, 2016
Apr 13, 2016
-
Wall Street Journal
Horizon Pharma Shares Tumble on Projected Earnings Details
-
The Street
Anavex Plays the Orphan Drug Stock Promotion Game
-
FierceBiotech
Baylor scientists ID dendritic cells as new cancer therapy targets
-
Food Dive
How medical foods offer growth opportunities for Nestle, packaged foods industry
Apr 12, 2016
Apr 11, 2016
Apr 08, 2016
-
FierceBiotech
FDA reviewers question efficacy, raise safety issues and cite a challenge on Clovis's rociletinib
-
PMLive
BMS' Opdivo gets two new indications in Europe
-
Bloomberg
Valeant Shares Have Best Three-Day Run in Almost 20 Years
-
Reuters
Suit that mimics life at age 85 has no creases, just creaks
Previous
